Chennai based Global Pharma recalls 50000 tubes of contaminated eye drops in US

Stating the reason for recall, the US health regulator said: "FDA analysis found unopened tubes to be contaminated with bacteria."

The company initiated the Class I recall on February 24 this year.

As per the USFDA, a Class I recall is the most urgent of the three types of FDA recalls and usually pertains to defective products that can cause serious health problems.

In February, Global Pharma Healthcare had announced that it is recalling its entire lot of eye drops allegedly linked to vision loss in the US.

Artificial Tears Lubricant eye drops are used as a protectant against irritation or to relieve dryness of the eye.

In a separate disclosure, the USFDA stated that Mumbai-based Sun Pharma is recalling 1,920 bottles of Dofetilide CapsulesDofetilide Capsules, which are used to treat irregular heartbeat.

The affected lot has been produced at Sun's Dadra-based plant, the USFDA stated.

The US-based unit of the company -- Sun Pharmaceutical Industries Inc -- is recalling the lot due to "Failed content uniformity specifications," it added.

The New Jersey based firm initiated the Class III recall on March 9.

As per USFDA, a Class III recall is initiated in a "situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences."